{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:09:59Z","timestamp":1793736599616,"version":"4.6.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Finerenone is a novel nonsteroidal mineralocorticoid receptor antagonist. However, robust evidence about its efficacy and safety in primary aldosteronism is scarce.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>In this prospective, multicenter, single-arm, and exploratory trial, we enrolled adults (aged \u226475 years) with primary aldosteronism, an office blood pressure (BP) ranging from 140 to 180\/90 to 120 mm\u2009Hg, and an estimated glomerular filtration rate \u226560 mL\/min per 1.73 m\u00b2. Eligible patients received finerenone (20\u201340 mg\/d) treatment for 12 weeks. The primary outcome was the change in daytime systolic BP at 12 weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Fifty-seven patients were ultimately treated. Per-protocol analysis revealed that finerenone treatment significantly reduced mean daytime systolic BP (\u22126.69\u00b11.60 mm\u2009Hg;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001) and diastolic BP (\u22124.55\u00b11.06 mm\u2009Hg;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001) according to ambulatory monitoring. Mean office BP decreased even more substantially (systolic BP, \u221215.58\u00b11.69 mm\u2009Hg; diastolic BP, \u22128.61\u00b11.02 mm\u2009Hg; both\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). The mean increase in serum potassium concentration was 0.39\u00b10.05 mmol\/L, and 94.5% of patients exhibited a normal concentration after 12 weeks of treatment (versus baseline 61.8%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). Plasma renin activity increased, and 32.7% of patients exhibited a plasma renin activity concentration \u22651 ng\/mL per h. According to the Primary Aldosteronism Medical Treatment Outcome criteria, 29.1% and 20.0% of patients achieved complete biochemical and clinical responses, respectively. Treatment was well tolerated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>This study demonstrated the efficacy and safety of finerenone in the treatment of primary aldosteronism, supporting its use as a potential alternative therapy for the condition. Nevertheless, further prospective and head-to-head randomized controlled trials are essential to establish finerenone as a viable substitute for spironolactone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>REGISTRATION:<\/jats:title>\n                    <jats:p>\n                      URL:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\">https:\/\/www.clinicaltrials.gov<\/jats:ext-link>\n                      ; Unique identifier: NCT06381323.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1161\/hypertensionaha.125.26048","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T10:00:15Z","timestamp":1769076015000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism: A Multicenter Prospective Study"],"prefix":"10.1161","volume":"83","clinical-trial-number":[{"clinical-trial-number":"nct06381323","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0244-0635","authenticated-orcid":true,"given":"Ping","family":"Li","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, China (P.L., F.Y., Z.Z., D.Z.)."},{"name":"Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, China (P.L., Y.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, China (P.L., F.Y., Z.Z., D.Z.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxing","family":"Lou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, China (P.L., Y.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7678-0400","authenticated-orcid":true,"given":"Ziwei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, China (P.L., F.Y., Z.Z., D.Z.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3956-6745","authenticated-orcid":true,"given":"Yunfeng","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Second People\u2019s Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, China (Y.D., J.Z.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Second People\u2019s Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, China (Y.D., J.Z.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4519-397X","authenticated-orcid":true,"given":"Yan","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, West China Hospital, Sichuan University, Chengdu (Y.R.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anli","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People\u2019s Republic of China, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing (A.T.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuoling","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Affiliated Zhongda Hospital of Southeast University, Nanjing, China (Z.X.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimin","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Soochow University, Suzhou, China (B.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism of the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, China (J.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0352-3865","authenticated-orcid":true,"given":"Libin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Fujian Medical University Union Hospital, Fuzhou, China (L.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, China (P.L., F.Y., Z.Z., D.Z.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.02.052"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.01.052"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/M20-0065"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002441"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60834-X"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-022-00730-2"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-065250"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00210-2"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00139"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12831"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000259805.18468.8c"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-2-199907200-00005"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4061"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2508629"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(24)00308-5"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0215"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa736"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2025845"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110956"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab777"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.124.071452"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvaf099"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01225-8"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-020-00570-5"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1159\/000541441"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/jch.14877"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/20406223241239775"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61538-4"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mbp.0000209086.32493.bd"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpae133"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02606-3"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-03955-5"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000003330"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-023-01412-w"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1125693"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115975"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000000091"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10360"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24031922"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2015.1059819"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004100878"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.0438-17"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000003813"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.125.26048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:01:16Z","timestamp":1777572076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.125.26048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.125.26048"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.125.26048","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2025-09-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}